Skip to main content
. Author manuscript; available in PMC: 2014 Jun 26.
Published in final edited form as: Vaccine. 2013 May 16;31(30):3079–3089. doi: 10.1016/j.vaccine.2013.04.052

Table 1.

Epidemiological parameters of the seasonal influenza model and their distributions

Variable Distribution References
Infectious period (ages 0–14) Gamma(Mean 3.6, Std 1.9) 19
Infectious period (ages 15+) Gamma(Mean 3.9, Std 1.9) 19
Latent period Triangular(Min 1, Mode 2, Max 3) 2023
Susceptibility (ages 0–3) Normal(Mean 0.83, Std 0.369) 24
Susceptibility (ages 4–17) Normal(Mean 0.49, Std 0.5) 24
Susceptibility (ages 18+) Normal(Mean 0.53, Std 0.49) 24
Reproductive number (R) Normal(Mean 1.3, Std 0.15, Min 1) 25
Case mortality (ages 0–4) Normal(Mean 4×10−5, Std 10−5, Min 0) 2
Case mortality (ages 5–17) 10−5 2
Case mortality (ages 18–49) Normal(Mean 9×10−5, Std 3×10−5, Min 0) 2
Case mortality (ages 50–64) Normal(Mean 134×10−5, Std 45×10−5, Min 0) 2
Case mortality (ages 65+) Normal(Mean 117×10−4, Std 39×10−4, Min 0) 2
Case hospitalization (ages 0–4) Normal(Mean 0.0141, Std 0.0047, Min 0) 2
Case hospitalization (ages 5–17) Normal(Mean 0.0006, Std 0.0002, Min 0) 2
Case hospitalization (ages 18–49) Normal(Mean 0.0042, Std 0.0014, Min 0) 2
Case hospitalization (ages 50–64) Normal(Mean 0.0193, Std 0.0064, Min 0) 2
Case hospitalization (ages 65+) Normal(Mean 0.0421, Std 0.0140, Min 0) 2
Proportion high risk (ages 0.5–1) Normal(Mean 0.0415, Std 0.0044, Min 0) 26
Proportion high risk (ages 2–5) Normal(Mean 0.0883, Std 0.0051, Min 0) 26
Proportion high risk (ages 5–18) Normal(Mean 0.1168, Std 0.0030, Min 0) 26
Proportion high risk (ages 19–24) Normal(Mean 0.1235, Std 0.0055, Min 0) 26
Proportion high risk (ages 25–49) Normal(Mean 0.1570, Std 0.0027, Min 0) 26
Proportion high risk (ages 50–64) Normal(Mean 0.3056, Std 0.0044, Min 0) 26
Proportion high risk (ages 65+) Normal(Mean 0.4701, Std 0.0050, Min 0) 26
High-risk relative mortality (ages 0–19) Triangular(Min 0.4, Mode 0.6, Max 21.9)/Triangular(Min 0.041, Mode 0.07, Max 0.30) 17
High-risk relative mortality (ages 20–64) Uniform(Min 0.8, Max 24.9)/Triangular(Min 0.21, Mode 0.31, Max 0.41) 17
High-risk relative mortality (ages 65+) Uniform(Min 23, Max 29.6)/Triangular(Min 2.3, Mode 3.51, Max 4.52) 17
High-risk relative hospitalization (ages 0–19) Uniform(Min 6.0, Max 21.4)/Uniform(Min 0.57, Max 6.9) 17
High-risk relative hospitalization (ages 20–64) Uniform(Min 6.9, Max 22.3)/Uniform(Min 1.5, Max 12.0) 17
High-risk relative hospitalization (ages 65+) Uniform(Min 33.3, Max 68.4)/Uniform(Min 12.5, Max 15.8) 17
Vaccine efficacy against infection (ages 0.5–15) Uniform(Min 0.54, Max 0.8) 27,28
Vaccine efficacy against infection (ages 16–64) Uniform(Min 0.54, Max 0.7) 27,28
Vaccine efficacy against infection (ages 65+) Uniform(Min 0.33, Max 0.66) 27,28
Vaccine efficacy against mortality Uniform(Min 0.39, Max 0.54) 16
Vaccine efficacy against hospitalization Uniform(Min 0.21, Max 0.73) 16,27

Std = standard deviation; Min = minimum; Max= maximum; Normal (Mean m, Std s, Min a) is the standard Normal (Mean m, Std s) random variable censored so that it has minimum a.